Hemophagocytic Lymphohistiocytosis in Adults: Spectrum of Severity, Therapy and Outcome

Hana Saleh; Jennifer Petts; Zuhair Ballas

doi:10.1016/j.jaci.2014.12.1540

Back

Hemophagocytic Lymphohistiocytosis in Adults: Spectrum of Severity, Therapy and Outcome

Abstract

Open access

Peer reviewed

Hemophagocytic Lymphohistiocytosis in Adults: Spectrum of Severity, Therapy and Outcome

Hana Saleh, Jennifer Petts and Zuhair Ballas

Journal of allergy and clinical immunology, Vol.135(2), pp.AB185-AB185

02/01/2015

DOI: 10.1016/j.jaci.2014.12.1540

Files and links (1)

url

https://doi.org/10.1016/j.jaci.2014.12.1540View

Published (Version of record) Open Access

Abstract

Rationale While the molecular etiology of primary HLH (pHLH) is well characterized, secondary HLH (sHLH) is less defined. sHLH is a heterogeneous entity whose severity and presentation vary depending on the underlying disease. [...]the HLH 2004 therapeutic protocol (developed for pHLH) may not be the best approach for all sHLH patients.

Drug therapy

Medical research

Palliative care

Details

Title: Subtitle: Hemophagocytic Lymphohistiocytosis in Adults: Spectrum of Severity, Therapy and Outcome
Creators: Hana Saleh - University of Iowa Health Care
Jennifer Petts - University of Iowa Health Care
Zuhair Ballas - University of Iowa
Resource Type: Abstract
Publication Details: Journal of allergy and clinical immunology, Vol.135(2), pp.AB185-AB185
Publisher: Elsevier Limited
DOI: 10.1016/j.jaci.2014.12.1540
ISSN: 0091-6749
eISSN: 1097-6825
Language: English
Date published: 02/01/2015
Academic Unit: Immunology; Internal Medicine
Record Identifier: 9984361722602771

Metrics

1 Record Views